Literature DB >> 35599255

Safety of zoledronate in older patients at high risk of fracture with reduced renal function.

A Sahota1, R Barbary2, M Cameron3, A-M Stewart2, O Sahota4,5,6,7.   

Abstract

Entities:  

Year:  2022        PMID: 35599255     DOI: 10.1007/s00198-022-06427-6

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   5.071


× No keyword cloud information.
  2 in total

1.  Alendronate use in older patients with reduced renal function: challenges and opportunities in clinical practice.

Authors:  N Naganathar; W -P Yau; Z H Mok; Z Y F Tan; S T H Chew
Journal:  Osteoporos Int       Date:  2021-03-15       Impact factor: 4.507

2.  Evaluation of estimated glomerular function (eGFR) versus creatinine clearance (CrCl) to predict acute kidney injury when using zoledronate for the treatment of osteoporosis.

Authors:  M Schini; N Peel; L Toronjo-Urquiza; E Thomas; S Salam; A Khwaja; R Eastell; J S Walsh
Journal:  Osteoporos Int       Date:  2021-10-15       Impact factor: 4.507

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.